Ceretype Neuromedicine is an AI-based fMRI brain biomarker technology to improve drug discovery and patient care.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1 Broadway
City: Cambridge
State: MA
Zip: 02142
Country: US
Ceretype Neuromedicine is an AI-based fMRI brain biomarker technology to improve drug discovery and patient care. Based in Cambridge Massachusetts, Ceretype is founded on seminal scientific discoveries made in the laboratory of Emily Stern, David Silbersweig, and Hong Pan at Brigham and Women’s Hospital/Harvard Medical School (BWH/HMS).
Contact Phone:
+12122093050
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2021 | Unattributed | $1.4M | 2/2023 | Pre Seed Round | $0 |
One Mind Accelerator One Mind Accelerator One Mind Accelerator One Mind Accelerator |
10/2021 | Convertible Note | 1 | - |
WPSS.bio WPSS.bio |
10/2021 | Convertible Note | 1 | - |
WPSS.bio WPSS.bio |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|